Successful treatment of idiopathic
hypersomnia and narcolepsy with modafinil.
Bastuji H; Jouvet M
Neurophysiologie Clinique, Hospital Neurologique, Lyon, France
Prog Neuropsychopharmacol Biol Psychiatry, 12(5):695-700 1988
Abstract:
1. Modafinil, a putative central alpha 1 adrenergic agonist, was tested in idiopathic hypersomnia and narcolepsy.
2. Sleep attacks and drowsiness were significantly decreased in 83% of 18 hypersomniac subjects and 71% of 24 narcoleptics.
3. When cataplectic episodes were not totally suppressed the association of a low dose of Clomipramine was successful in improving them.
4. Modafinil, used for at least 3 years in some patients, produces, in most cases, no peripheric sides effects, does not disturb night sleep and is never responsible of tolerance of drug dependence.
Modafinil research
1. Modafinil for sustaining the alertness of helicopter pilots
2. Modafinil augmentation of antidepressant treatment
3. Modafinil the unique properties of a new stimulant
4. Modafinil children with attention-deficit/hyperactivity disorder
5. Modafinil tolerability in healthy male volunteers
6. Modafinil successful treatment of hypersomnia & narcolepsy
7. Modafinil narcolepsy: symptoms and management
8. Modafinil amplification of cortical serotonin release
9. Modafinil treatment of alcoholic organic brain syndrome
10. Modafinil effect on melatonin, cortisol, and growth hormone
11. Modafinil in obstructive sleep apnea-hypopnea syndrome